Classification of chemotherapeutic agents by mechanism of action modified according to Smith et al6
Mechanism of action/substance group . | Agent . |
---|---|
Alkylating agents | |
Nitrogen mustard | Chlorambucil, cyclophosphamide, ifosfamide, melphalan |
Nitrosourea | Carmustine, lomustine |
Platinum-based | Carboplatin, cisplatin, oxaliplatin |
Alkylsulfonate | Busulfan, treosulfan |
Hydrazine | Procarbazine |
Triazene | Dacarbazine |
Aziridine | Thiotepa |
Antimetabolites | |
Folic acid | Methotrexate |
Purine antagonist | Cladribine, clofarabine, fludarabine, mercaptopurine |
Pyrimidine antagonist | Cytarabine, decitabine, azacitidine, fluorouracil, gemcitabine |
Antitubulin | |
Taxane | Docetaxel, paclitaxel |
Vinca alkaloid | Vinblastine, vincristine, vindesine, vinorelbine |
Topoisomerase II inhibitors | |
Epipodophyllotoxin | Etoposide, teniposide |
Intercalating agents | |
Anthracycline29,30 | Daunorubicin, doxorubicin, epirubicin, idarubicin |
Anthracenedione31,32 | Mitoxantrone |
Streptomyces33 | Actinomycin, bleomycin, mitomycin |
Mechanism of action/substance group . | Agent . |
---|---|
Alkylating agents | |
Nitrogen mustard | Chlorambucil, cyclophosphamide, ifosfamide, melphalan |
Nitrosourea | Carmustine, lomustine |
Platinum-based | Carboplatin, cisplatin, oxaliplatin |
Alkylsulfonate | Busulfan, treosulfan |
Hydrazine | Procarbazine |
Triazene | Dacarbazine |
Aziridine | Thiotepa |
Antimetabolites | |
Folic acid | Methotrexate |
Purine antagonist | Cladribine, clofarabine, fludarabine, mercaptopurine |
Pyrimidine antagonist | Cytarabine, decitabine, azacitidine, fluorouracil, gemcitabine |
Antitubulin | |
Taxane | Docetaxel, paclitaxel |
Vinca alkaloid | Vinblastine, vincristine, vindesine, vinorelbine |
Topoisomerase II inhibitors | |
Epipodophyllotoxin | Etoposide, teniposide |
Intercalating agents | |
Anthracycline29,30 | Daunorubicin, doxorubicin, epirubicin, idarubicin |
Anthracenedione31,32 | Mitoxantrone |
Streptomyces33 | Actinomycin, bleomycin, mitomycin |